Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

NCT04331041 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Cancer of the Pancreas
Pancreas Adenocarcinoma

Interventions

DEVICE: Adaptive stereotactic body radiation therapy
DRUG: Defactinib
PROCEDURE: Tumor biopsy
PROCEDURE: Research blood draw

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]